Mounting a fightback: Covid-19 vaccine developers reach last leg of trials

The race to a Covid-19 vaccine picked up this week as many developers reached the last leg of their trials. As US regulators tighten the scrutiny around approvals, companies have announced their intention to put their trial data in public domain for scientific enquiry to remove any doubt about safety …

Read moreMounting a fightback: Covid-19 vaccine developers reach last leg of trials

To get approval in India, vaccines must work in at least 50% cases

Mumbai: Companies working on Covid-19 vaccine in India will have to demonstrate that at least half the people who receive it are protected from the infection and that it induces superior antibody and cellular responses to get their vaccine approved. Vaccines developed outside of India can apply for marketing authorisation …

Read moreTo get approval in India, vaccines must work in at least 50% cases